Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-06-04

Clinical Trial Update: Post-discharge Malaria Chemoprevention(PMC) Study [Phase 3]

View source ↗

Summary

A Phase 3 trial update on post-discharge malaria chemoprevention following severe malaria hospitalization is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: Malaria, Severe Anemia | Phase 3 | Status: COMPLETED